Limitations of current medical treatments for depression: disturbed circadian rhythms as a possible therapeutic target.
The proportion of diagnosed depressives prescribed antidepressants has increased markedly over the last 20 years, mainly following the introduction of the selective serotonin reuptake inhibitors. However, currently available antidepressants have notable limitations, relating to their only moderate efficacy relative to placebo, relatively slow onset of action, possible withdrawal symptoms, and problems of compliance. Sleep disturbances are often used to identify newly presenting depressive patients, and may be part of a more general alteration of bodily rhythms. There are links between pharmacological treatments and circadian rhythms in depression, which might represent another, new option for the development of a therapeutic approach to depression treatment. Many antidepressants affect sleep, some are sedative, and others have been used specifically in severely insomniac depressives. Disturbances in circadian rhythms may be an integral part of depressive mechanisms, and normalising them via an innovative mechanism of antidepressant action may be a fruitful avenue in the search for improved antidepressant agents.
Lader
Malcolm
M
PO Box 56, Institute of Psychiatry, Denmark Hill, London SE5 8AF, United Kingdom. Malcolm.Lader@iop.kcl.ac.uk
D000928:Antidepressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002940:Circadian Rhythm / Q000187:drug effects*; D003863:Depression / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D004361:Drug Tolerance; D006801:Humans; D012893:Sleep Wake Disorders / Q000209:etiology*; D013405:Suicide
D000928:Antidepressive Agents